Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review.
Cell Biochem Funct
; 39(1): 4-9, 2021 Jan.
Article
en En
| MEDLINE
| ID: mdl-32803762
ABSTRACT
Since the new coronavirus known as 2019-nCoV (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has widely spread in Wuhan, China, with severe pneumonia, scientists and physicians have made remarkable efforts to use various options such as monoclonal antibodies, peptides, vaccines, small-molecule drugs and interferon therapies to control, prevent or treatment infections of 2019-nCoV. However, no vaccine or drug has yet been confirmed to completely treat 2019-nCoV. In this review, we focus on the use of potential available small-molecule drug candidates for treating infections caused by 2019-nCoV.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Antivirales
/
SARS-CoV-2
/
Tratamiento Farmacológico de COVID-19
Límite:
Humans
País/Región como asunto:
Asia
Idioma:
En
Revista:
Cell Biochem Funct
Año:
2021
Tipo del documento:
Article
País de afiliación:
Irán